In this issue we focus on the topic of Epigenetics, the study of heritable phenotypic traits not encoded by the genetic sequence. While every cell in your body has a copy of your genetic code in the form of DNA, many of the unique features between different cell types and between different individuals arise from unique patterns of gene expression. In recent decades, it has become increasingly clear that these traits are dictated by an extra layer of information which is inheritable but not directly encoded in the genetic sequence: hence the prefix, "epi-" from the Greek "on top of" or "outside of." Epigenetic information can be encoded in a variety of ways, altering chromosomes in order to favor expression or silencing of certain genes in response to cellular signals, environmental factors, or developmental cues. Importantly, cells have a variety of enzymes and mechanisms responsible for maintaining the epigenetic state throughout the cell's life cycle and reproduction, allowing these patterns of expression to be inherited.
The molecular mechanisms of epigenetics typically involve physical or chemical modifications of the chromosomes. In the nucleus, the DNA is wrapped around histone proteins, providing a structural scaffold to tightly condense the genome for storage and requiring biochemical regulation to provide access for transcribing genes. Chemical modifications to the histone proteins or the DNA molecules can recruit specific binding proteins or alter the physical arrangement of the chromosome. On top of that, regulatory interactions of non-coding RNAs, which are transcribed but function without coding for proteins, can provide an additional layer of control on transcription and translation across the genome. The field of epigenetics has seen a rapid expansion in recent years, as new techniques have allowed researchers to precisely measure broad patterns of gene expression and to probe the locations of specific epigenetic marks and DNAbinding proteins. By addressing how these marks are initiated and maintained and how they result in observable phenotypic traits, researchers can uncover new modes of regulation and complex interactions. Studies of epigenetic mechanisms have enabled insights into human development (such as stem cell maintenance and tissue differentiation) and diseases (especially cancers) and provide promising targets for therapeutic approaches.
In this issue of the Yale Journal of Biology and Medicine, we present articles spanning the breadth and depth of epigenetics research, either focusing on the wide variety of roles of a particular mechanism (such as a type of non-coding RNA) or investigating the assortment of mechanisms at play in a particular case (such as a certain cancer or cell type).
First in this issue, Connelly et al. present an original research article investigating the inhibition of a chromatin modulator as a novel combined approach to enhance the chemotherapeutic activity of doxorubicin. They show that the application of a chromodomain inhibitor enhanced the toxicity of doxorubicin in cultured glioblastoma and breast cancer cells. This work could lead to future chemotherapeutic strategies with improved response in patients, by development of related compounds or discovery of novel drug molecules acting through epigenetic mechanisms.
Ehrlich et al. use bioinformatic analyses to identify genes that are differentially expressed in skeletal muscle compared to cardiac muscle, to brain tissue, and to muscle progenitor cells in culture to probe the function of DNA hypomethylation in enhancer regions. They show that DNA hypomethylation of these enhancers correlates nicely with tissue-specific expression and speculate that this epigenetic modulation may help establish or maintain the enhancer function. In addition, they clone one of these enhancer elements into a reporter and demonstrate high levels of expression in a myoblast cell line, but not in a breast-cancer cell line, and that the expression is regulated by DNA methylation. Repeats/Cas9 nuclease systems (CRISPR/Cas9 †) (frequently used for editing the genome in a sequence-specific manner) for making epigenetic changes such as editing regulatory regions of DNA or introducing epigenetic marks to specific sites in the genome. They present some of the recent findings that have been enabled by these new tools, focusing on insights into epigenetic regulation in neuronal development and function.
A review by Enriquez discusses the limitations of current techniques for editing the epigenome, and recent developments of novel CRISPR techniques can refine our understanding of the functions of the epigenome. This review details the molecular modifications to the CRISPR system to modify histones for transcriptional activation or repression, with a particular focus on the structural biology involved. Enriquez predicts some potential future clinical applications of epigenome editing including breast and cervical cancers with BRCA1 mutations, neurogenetic diseases like Prader-Willi syndrome and Angelman syndrome, and viral infections with HIV or HSV1.
Evsikov and Marín de Evsikova present a review on epigenetic regulation of transposable elements (TEs), stretches of DNA which have the ability to copy themselves and spread within an organism's genome. While it is often believed that TEs contribute to genomic instability because the copying and insertion can be disruptive, the authors argue here that transposable elements play an important role in early embryonic development. They discuss evidence that the epigenetic regulation of transposons may be important in regulating the widespread epigenomic changes that occur in the early embryo and may provide a new mechanism for adaptability in the genome.
Next, Blumenstiel et al. provide a thoughtful review of piRNAs, a type of small non-coding RNA which target and silence particular genes in a sequence-specific manner. Interestingly, piRNAs often target transposable elements, serving as a genome defense system to prevent the instability resulting from TEs. In discussing the evolutionary pressures on piRNA sequence specificity, the authors present a hypothesis of "genomic autoimmunity" which could drive the adaptive evolution of piRNA machinery by discouraging piRNA from targeting the organism's own genome.
Additionally, a review by O'Connor et al. thoroughly examine the mechanisms of transcriptional regulation mediated by Sp1, a member of the Specificity factor/Kruppel-like factor family of transcription factors. Sp1 is ubiquitously expressed in mammalian cells, and can influence tissue-specific maturation of hematopoietic cells through its role in changing gene expression.
O'Connor and colleagues also discuss the role of Sp1 in cancer growth, as well as manipulations of Sp1 in cancer treatment.
Cortés-López and Miura review what is known about circular RNA species, which are non-coding RNAs that have had the 3' end sealed onto the 5' end. This review details the methods currently available to study circular RNA species, and the development of hypotheses concerning the function of circular RNA including: reducing transcription and protein levels of its gene of origin, reducing the effects of microRNAs, sequestering proteins, and influencing synaptic plasticity in neural tissues.
Next, Dr. Bayarsaihan provides an extensive review of the epigenetic mechanisms involved in the development and differentiation of dental pulp stem cells, a key component in tooth development. The author discusses the many epigenetic modifications in embryonic stem cells and important marks which are lost or gained as the dental pulp stem cells develop. These features are of interest not only for understanding dental development and diseases but also as targets for stem cell engineering and tissue regeneration applications.
Next, Hilliard and El-Dahr review the roles of epigenetic modifiers in renal cell differentiation and development and how aberrations in these modifications contribute to acute and chronic kidney diseases. They also note several therapeutic approaches that act through epigenetic mechanisms and suggest that future innovations such as epigenetic targeting or stem cell-based regeneration may provide alternatives to typical treatments such as dialysis or transplantation.
Iguchi et al. present a well-written review of epigenetic factors in pancreatic cancer, one of the most devastating cancers and one with few treatment options. The authors discuss the fundamental biological findings and translational progress in understanding the epigenetic changes involved in pancreatic cancer, including the extensive crosstalk between epigenetic pathways.
Peter Cockerill reviews 20 years of work from his lab detailing mechanisms involved in gene induction in T cells following primary infection that allows for the memory effect of adaptive immunity in subsequent infections. Primary infection yields inducible binding of the transcription factor AP-1, which recruits binding of additional transcription factors, such as RUNX1. RUNX1 and additional transcription factors remain even after recovery from primary infection, and contribute to epigenetic destabilization of nucleosomes, allowing for easy access for transcription in future infections. Acute Myeloid Leukemia frequently results from mutations in this pathway, which disrupt the localization and binding of the transcription factors that prime immunological memory in lymphocytes.
Finally, a short review by Li et al. discusses what is known about epigenetic mechanisms in a variety of eye diseases, including age-related macular degeneration and cataracts, retinoblastoma and others. Interestingly, many ophthalmic disorders develop with advanced aging or are affected by environmental exposure, events which are also accompanied numerous specific epigenetic changes. The authors note a number of studies of the roles of epigenetics in the development, diagnosis and treatment of these disorders.
Our understanding of epigenetics is far from complete, with novel discoveries and new insights evolving rapidly. We hope the articles in this issue convey the broad implications of epigenetic mechanisms and highlight the fascinating research and promising future work for the field.
